XML 53 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Taxes  
Schedule of income (loss) from continuing operations before income taxes

Year ended December 31,

    

2023

    

2022

    

2021

(in thousands)

Domestic

$

(33,383)

$

47,368

$

23,561

Foreign

 

5,045

 

3,617

 

2,119

Total

$

(28,338)

$

50,985

$

25,680

Schedule of components of the expense (benefit) for income taxes

Year ended December 31,

    

2023

    

2022

    

2021

(in thousands)

Current:

Federal

$

3,299

$

$

Foreign

 

1,136

 

1,506

 

183

State and local

 

(194)

 

577

 

110

Total current expense (benefit) for income taxes

 

4,241

 

2,083

 

293

Deferred:

Federal

 

(3,026)

 

(96,811)

 

119

Foreign

 

512

 

(484)

 

(507)

State and local

 

303

 

(20,745)

 

(263)

Total deferred expense (benefit) for income taxes

 

(2,211)

 

(118,040)

 

(651)

Total expense (benefit) for income taxes

$

2,030

$

(115,957)

$

(358)

Schedule of reconciliation of the income tax expense computed using the Federal statutory rate to actual income tax provision

Year ended December 31,

    

2023

    

2022

    

2021

(in thousands)

Income tax expense (benefit) at U.S. statutory rates

$

(5,951)

$

10,706

$

5,393

State taxes, net of U.S. federal impact

 

1,073

 

1,101

 

(607)

Effect of international operations

 

(7,668)

 

(11,149)

 

609

Research and development tax credit

 

(7,287)

 

(6,470)

 

(3,964)

Net change in valuation allowance

 

662

 

(104,972)

 

(2,389)

Change in accrual for unrecognized tax benefits

 

(369)

 

3,349

 

398

Share-based compensation

2,084

606

1,208

Extinguishment of debt

19,289

(1,090)

Adoption of new accounting standard

(9,295)

Other

 

197

 

167

 

84

Total expense (benefit) for income taxes

$

2,030

$

(115,957)

$

(358)

Schedule of deferred tax assets and liabilities

December 31,

    

2023

    

2022

(in thousands)

Deferred tax assets: 

Inventory valuation

 

$

12,682

$

11,931

Net operating losses

5,841

 

5,647

Credit carry forwards

49,086

59,988

Warranty and installation accruals

1,766

 

1,862

Share-based compensation

4,637

 

5,267

Contract liabilities

19,785

24,504

Operating leases

8,034

8,349

Research and experimental ("R&E") capitalization

34,504

19,071

Other

4,885

 

6,553

Total deferred tax assets

141,220

 

143,172

Valuation allowance

(11,745)

 

(11,083)

Net deferred tax assets

129,475

 

132,089

Deferred tax liabilities: 

Purchased intangible assets

14,166

 

8,724

Convertible Senior Notes

(39)

Operating leases

5,548

5,994

Depreciation

(1,588)

 

2,346

Total deferred tax liabilities

18,126

 

17,025

Net deferred taxes

 

$

111,349

$

115,064

Schedule of reconciliation of beginning and ending amount of uncertain tax positions

December 31,

    

2023

    

2022

    

2021

(in thousands)

Balance at beginning of year

$

16,110

$

12,761

$

12,363

Additions for tax positions related to current year

 

2,596

 

4,180

 

2,642

Additions for tax positions related to prior years

 

83

 

 

50

Reductions for tax positions related to prior years

 

(3,048)

 

(731)

 

(1,196)

Settlements

 

 

(100)

 

(1,098)

Balance at end of year

$

15,741

$

16,110

$

12,761